Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Major improvement in thyroid cancer survival of elderly patients in the Nordic countries

F. Zitrický, A. Koskinen, V. Liska, A. Försti, A. Hemminki, K. Hemminki

. 2024 ; 190 (3) : K32-K36. [pub] 20240302

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006812

Grantová podpora
856620 European Union's Horizon 2020
Jane and Aatos Erkko Foundation
Sigrid Juselius Foundation
Finnish Cancer Organizations
University of Helsinki
Helsinki University Central Hospital
Novo Nordisk Foundation
Päivikki and Sakari Sohlberg Foundation
Cooperatio Program
SURG
LX22NPO5102 National Institute for Cancer Research
European Union-Next Generation EU

OBJECTIVES: We describe age-specific survival in thyroid cancer (TC) from Denmark, Finland, Norway, and Sweden over a 50-year period. DESIGN: Population-based survival study. METHODS: Relative 5-year survival data were obtained from the NORDCAN database for the years 1972-2021. RESULTS: In the first period 1972-1976, 5-year survival in TC in Finland, Norway, and Sweden was 90% or higher, but a strong negative step-wise age gradient was observed, which was worse for men than women. Over time, survival increased, and in the final period, 2017-2021, survival for all women and Danish men up to age 69 years was about 90% or higher and, for men from the other countries, only marginally lower. Even for older women survival reached 80%, for older men somewhat less. CONCLUSIONS: Age disadvantage in TC survival was for the most part corrected over the 50-year period, and the remaining task is to boost survival for the oldest patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006812
003      
CZ-PrNML
005      
20240423155516.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ejendo/lvae015 $2 doi
035    __
$a (PubMed)38436478
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Zitrický, František $u Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen 30605, Czech Republic
245    10
$a Major improvement in thyroid cancer survival of elderly patients in the Nordic countries / $c F. Zitrický, A. Koskinen, V. Liska, A. Försti, A. Hemminki, K. Hemminki
520    9_
$a OBJECTIVES: We describe age-specific survival in thyroid cancer (TC) from Denmark, Finland, Norway, and Sweden over a 50-year period. DESIGN: Population-based survival study. METHODS: Relative 5-year survival data were obtained from the NORDCAN database for the years 1972-2021. RESULTS: In the first period 1972-1976, 5-year survival in TC in Finland, Norway, and Sweden was 90% or higher, but a strong negative step-wise age gradient was observed, which was worse for men than women. Over time, survival increased, and in the final period, 2017-2021, survival for all women and Danish men up to age 69 years was about 90% or higher and, for men from the other countries, only marginally lower. Even for older women survival reached 80%, for older men somewhat less. CONCLUSIONS: Age disadvantage in TC survival was for the most part corrected over the 50-year period, and the remaining task is to boost survival for the oldest patients.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    _2
$a míra přežití $7 D015996
650    _2
$a rizikové faktory $7 D012307
650    12
$a nádory štítné žlázy $x terapie $7 D013964
650    _2
$a incidence $7 D015994
650    _2
$a registrace $7 D012042
650    _2
$a věkové rozložení $7 D017677
651    _2
$a Skandinávie a severské státy $x epidemiologie $7 D012537
651    _2
$a Finsko $x epidemiologie $7 D005387
651    _2
$a Norsko $x epidemiologie $7 D009664
651    _2
$a Švédsko $x epidemiologie $7 D013548
651    _2
$a Dánsko $x epidemiologie $7 D003718
655    _2
$a časopisecké články $7 D016428
700    1_
$a Koskinen, Anni $u Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, 00029 Helsinki, Finland $u Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, 00029 Helsinki, Finland
700    1_
$a Liska, Vaclav $u Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen 30605, Czech Republic $u Biomedical Center, Charles University Medical School, 32300 Pilsen, Czech Republic
700    1_
$a Försti, Asta $u Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
700    1_
$a Hemminki, Akseli $u Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00029 Helsinki, Finland $u Comprehensive Cancer Center, Helsinki University Hospital, 00029 Helsinki, Finland $1 https://orcid.org/0000000171038530
700    1_
$a Hemminki, Kari $u Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen 30605, Czech Republic $u Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg D-69120, Germany $1 https://orcid.org/0000000227693316 $7 mzk20201092711
773    0_
$w MED00009634 $t European journal of endocrinology $x 1479-683X $g Roč. 190, č. 3 (2024), s. K32-K36
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38436478 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155512 $b ABA008
999    __
$a ok $b bmc $g 2081033 $s 1216579
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 190 $c 3 $d K32-K36 $e 20240302 $i 1479-683X $m European journal of endocrinology $n Eur J Endocrinol $x MED00009634
GRA    __
$a 856620 $p European Union's Horizon 2020
GRA    __
$p Jane and Aatos Erkko Foundation
GRA    __
$p Sigrid Juselius Foundation
GRA    __
$p Finnish Cancer Organizations
GRA    __
$p University of Helsinki
GRA    __
$p Helsinki University Central Hospital
GRA    __
$p Novo Nordisk Foundation
GRA    __
$p Päivikki and Sakari Sohlberg Foundation
GRA    __
$p Cooperatio Program
GRA    __
$p SURG
GRA    __
$a LX22NPO5102 $p National Institute for Cancer Research
GRA    __
$p European Union-Next Generation EU
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace